Non disponible en dehors du Royaume-Uni et de l'Irlande
Application
Farnesyltransferase inhibitor 277 (FTI-277) has been used to:inhibit protein farnesylation in breast cell lines.in marrow-isolated adult multilineage inducible cells (MIAMI).inhibition of farnesyl transferase in CV-1 in Origin with SV40 genes cells (COS-7).
Biochem/physiol Actions
Farnesyltransferase inhibitor 277 (FTI-277) mediates apoptosis in multiple myeloma and is regarded as a potential therapeutic agent.
Highly potent (pM/nM) Ras CAAX peptidomimetic which antagonizes both H and K-Ras oncogenic signaling. Inhibitor of farnesyltransferase (Ftase) IC50 = 50 nM.
Packaging
Very hygroscopic material, package in a dry room with deoxygenated MeOH and pump down the solvent. Store with desiccant.
1, 5 mg in glass bottle
Ce produit répond aux critères suivants pour être admissible aux récompenses suivantes :